Aller au contenu principal
Profil bibliographique

Sai Murng

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

30Publications signalées
2003Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Immunodeficiency and Autoimmune DisordersCoagulation, Bradykinin, Polyphosphates, and AngioedemaHemophilia Treatment and ResearchGenomics and Rare DiseasesFood Allergy and Anaphylaxis Research

Les publications récentes

2025 article OpenAlex

National Audit of Long‐Term Real‐World Outcomes of Berotralstat Use in UK Patients With Hereditary Angioedema

Haggar Elbashir, Anthony D. Dorr, Manisha Ahuja, Lorena Lorenzo et autres

The data that support the findings of this study are available from the corresponding author upon reasonable request. Appendix S1: all70086-sup-0001-AppendixS1.docx. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any …

gb (code pays fourni par la source)

2 citations Allergy
Accès ouvert 2025 article OpenAlex

Chronic norovirus infection in immunodeficiency: A UK national case series

Alexandros Grammatikos, Anisha Mangtani, Mark Ponsford, Stephen Jolles et autres

Norovirus is a highly contagious virus that causes gastroenteritis. In healthy individuals, infection typically resolves in a few days, but certain populations are at higher risk of chronicity, including those with immunodeficiency. Chronic norovirus infection (CNI) can be debilitating in these patients, …

gb (code pays fourni par la source)

6 citations The Journal of Allergy and Clinical Immunology In Practice
Accès ouvert 2025 article OpenAlex

A multi-centre UK-based survey on angioedema secondary to acquired C1 inhibitor deficiency

Hadeil Morsi, Aarnoud Huissoon, Alexandros Grammatikos, Andrew Whyte et autres

BACKGROUND: Acquired angioedema due to C1-inhibitor deficiency (AAE-C1-INH) is very rare compared to its prototype, hereditary angioedema. An updated characterization of the AAE-C1-INH cohort in the UK is required to inform management. OBJECTIVES: To describe the disease burden of AAE-C1-INH, long-term prophylaxis …

gb, us, au (code pays fourni par la source)

4 citations Clinical & Experimental Immunology
Accès ouvert 2023 article OpenAlex

Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma

Ekaterina Minskaia, Jesmeen Maimaris, Persephone Jenkins, Adriana S. Albuquerque et autres

The transcription factor STAT6 (Signal Transducer and Activator of Transcription 6) is a key regulator of Th2 (T-helper 2) mediated allergic inflammation via the IL-4 (interleukin-4) JAK (Janus kinase)/STAT signalling pathway. We identified a novel heterozygous germline mutation STAT6 c.1255G > C, …

gb, de (code pays fourni par la source)

44 citations Journal of Clinical Immunology
Accès ouvert 2023 article OpenAlex

A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom

Patrick Yong, Tanya Coulter, Tariq El‐Shanawany, Tomaz Garcez et autres

BACKGROUND: Detailed demographic data on people with hereditary angioedema (HAE) and acquired C1 inhibitor deficiency in the United Kingdom are relatively limited. Better demographic data would be beneficial in planning service provision, identifying areas of improvement, and improving care. OBJECTIVE: To obtain …

gb (code pays fourni par la source)

21 citations The Journal of Allergy and Clinical Immunology In Practice
Accès ouvert 2023 article OpenAlex

Practical challenges for functional validation of STAT1 gain of function genetic variants

Adriana S. Albuquerque, Jesmeen Maimaris, Alexander J McKenna, Jonathan Lambourne et autres

Wider application of next generation genetic sequencing (NGS) has significantly improved diagnosis for patients with inborn errors of immunity (IEI) and is increasingly a routine part of clinical practice [1, 2]. However, functional validation of genetic variants of unknown significance (VUS) remains …

gb (code pays fourni par la source)

3 citations Clinical & Experimental Immunology
Accès ouvert 2023 article OpenAlex

Berotralstat for the prophylaxis of hereditary angioedema—Real‐world evidence data from the United Kingdom

Manisha Ahuja, Anthony D. Dorr, Eniola Bode, Anne Boulton et autres

AppendixS1 AppendixS2 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

gb, us (code pays fourni par la source)

19 citations Allergy
Accès ouvert 2022 article OpenAlex

Lanadelumab for the prevention of hereditary angioedema attacks: A real‐world UK audit

Anthony D. Dorr, Charu Chopra, Tanya Coulter, John Dempster et autres

Appendix S1: Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

gb, us (code pays fourni par la source)

17 citations Allergy
Accès ouvert 2022 article OpenAlex

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

Adrian Shields, Ariharan Anantharachagan, Gururaj Arumugakani, Kenneth F. Baker et autres

In March 2020, the United Kingdom Primary Immunodeficiency Network (UKPIN) established a registry of cases to collate the outcomes of individuals with PID and SID following SARS-CoV-2 infection and treatment. A total of 310 cases of SARS-CoV-2 infection in individuals with PID …

gb (code pays fourni par la source)

35 citations Clinical & Experimental Immunology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.